Indication
Tumor mutational burden-high
1 clinical trial
1 product
Clinical trial
PHASE 2 STUDY OF IMC-001 IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED TMB-H SOLID TUMORStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Product
IMC-0011 clinical trial
1 product